![]() His Methotrexate research is multidisciplinary, incorporating perspectives in Dermatology, Erythrocyte sedimentation rate, Inverse Association and Orthopedic surgery. Weinblatt combines subjects such as Proportional hazards model, Hazard ratio, Prospective cohort study, Flow cytometry and Cohort with his study of Arthritis. His study looks at the relationship between Rheumatology and fields such as Family medicine, as well as how they intersect with chemical problems. His Rheumatoid arthritis study combines topics in areas such as Clinical trial, Randomized controlled trial, Surgery, Adverse effect and Placebo. His Internal medicine study incorporates themes from Gastroenterology and Physical therapy. His primary areas of investigation include Internal medicine, Rheumatoid arthritis, Rheumatology, Arthritis and Methotrexate. In his most recent research, the most cited papers focused on: Efficacy and Safety of ABT‐494, a Selective JAK‐1 Inhibitor, in a Phase IIb Study in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate (119 citations).Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis (328 citations). ![]() Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis (361 citations).His studies in Arthritis integrate themes in fields like Prospective cohort study and Severity of illness. His Rheumatology research focuses on Family medicine and how it relates to Coronavirus disease 2019 and Pandemic. He has researched Rheumatoid arthritis in several fields, including Adverse effect, Physical therapy, Methotrexate and Cohort. His Placebo research incorporates elements of Golimumab and Surgery. His Internal medicine research includes elements of Gastroenterology and Placebo. His primary scientific interests are in Internal medicine, Rheumatoid arthritis, Rheumatology, Adalimumab and Arthritis. In recent papers he was focusing on the following fields of study: What were the highlights of his more recent work (between 2015-2021)? In his study, which falls under the umbrella issue of Rheumatology, Infliximab is strongly linked to Etanercept. His research ties Prospective cohort study and Arthritis together. His Methotrexate research includes themes of Toxicity, Chemotherapy and Pharmacology. His Rheumatoid arthritis research is multidisciplinary, relying on both Adverse effect, Physical therapy, Clinical trial and Randomized controlled trial. His studies deal with areas such as Gastroenterology, Placebo and Surgery as well as Internal medicine. Weinblatt focuses on Internal medicine, Rheumatoid arthritis, Methotrexate, Arthritis and Immunology. What are the main themes of his work throughout his whole career to date? American college of rheumatology preliminary definition of improvement in rheumatoid arthritis (2276 citations).Principal components analysis corrects for stratification in genome-wide association studies (7332 citations).His research integrates issues of Connective tissue disease and Abatacept in his study of Surgery. ![]() Weinblatt examines in his Rheumatology study include Pharmacy, Predictive value of tests, Gold standard, Physical therapy and Etanercept. His study in Arthritis is interdisciplinary in nature, drawing from both Oncology, Autoantibody, Erythrocyte sedimentation rate, Hazard ratio and Platelet activation. ![]() His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Placebo. His biological study spans a wide range of topics, including Clinical trial, Severity of illness and Cohort study. Rheumatoid arthritis, Internal medicine, Arthritis, Rheumatology and Surgery are his primary areas of study. What is he best known for? The fields of study he is best known for:
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |